Table 1.

Demographic and clinical characteristics of N-acetyl-L-cysteine treated patients

Patient	Age (years)	Sex	Type of infection	Pathogen	Outcome
1	86	F	Pneumonia	Pseudomomas aeruginosa	Survived
2	54	F	Pneumonia	Klebsiella pneumoniae1	Died (MOF)
3	52	F	Pneumonia	Escherichia coli	Survived
4	52	F	Pneumonia	Staphylococcus aureus	Survived
5	67	M	Pneumonia	P. aeruginosa	Survived
6	37	M	Pneumonia	K. pneumoniae	Died (MOF)
7	39	M	Peritonitis	Enterococus faecalis	Survived
8	70	M	Peritonitis	S. aureus1	Survived
9	90	M	Pneumonia	P. aeruginosa	Survived
10	45	F	Pneumonia	S. aureus	Survived
11	82	M	Pneumonia	E. faecalis1	Died (PE)
12	70	M	Pneumonia	P. aeruginosa	Survived
13	82	M	Pneumonia	E. faecalis	Survived
14	65	F	Peritonitis	E. coli1	Survived
15	80	M	Pneumonia	Streptococcus pneumoniae	Died (PE)
16	72	M	Pneumonia	P. aeruginosa1	Survived
17	70	F	Pneumonia	E. faecalis	Survived
18	70	F	Peritonitis	S. aureus	Survived
19	70	M	Pneumonia	K. pneumoniae	Died (CD)
20	62	F	Pneumonia	S. aureus	Survived
21	55	M	Pneumonia	S. aureus1	Survived
22	70	F	Peritonitis	E. coli1	Survived
23	90	M	Pneumonia	E. faecalis	Died (MOF)
24	65	F	Pneumonia	E. coli1	Survived
25	60	M	Pneumonia	S. pneumoniae	Died (MOF)
26	65	F	Pneumonia	E. faecalis1	Survived
27	60	F	Peritonitis	E. faecalis, E. coli1	Survived

¹Isolated from blood. CD, cardiac death; MOF, multiple organ failure; PE, pulmonary embolism.